Last reviewed · How we verify
NCT06151379
Muscle Parameters and Pathological Response in Breast Cancer Patients
trial testing Neoadjuvant therapy in Neoadjuvant Chemotherapy in 69 participants. Completed in 20 October 2023.
30 September 2023
Quick facts
| Lead sponsor | Acıbadem Atunizade Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 69 |
| Start date | 1 March 2023 |
| Primary completion | 30 September 2023 |
| Estimated completion | 20 October 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Neoadjuvant therapy — full drug profile →
Conditions studied
- Neoadjuvant Chemotherapy — all drugs for Neoadjuvant Chemotherapy →
Sponsor
Acıbadem Atunizade Hospital
Who can join
Adults 29 to 72, female only, with Neoadjuvant Chemotherapy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators aimed to accurately measure muscle mass and predict pCR to NAC and its effect on clinical outcomes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06151379
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Neoadjuvant therapy
Trials testing the same drug.
- NCT07103395 — A Study Evaluating Neoadjuvant Chemotherapy, Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade · Phase 2 · recruiting
- NCT06734702 — Neoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunotherapy for · Phase 3 · recruiting
- NCT06642428 — Effect of Vitamin D Supplementation on the Efficacy and Adverse Effects of Neoadjuvant Therapy in Patients with Breast C · NA · recruiting
- NCT05441098 — Construction and Validation of an Assessment Model of PCR After NAT on Breast Cancer Patients With AI Technology · unknown
- NCT05642104 — The Detection of Cell-in-cell Structure (CICs) in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy · unknown
Other recruiting trials for Neoadjuvant Chemotherapy
Currently open trials in the same condition.
- NCT06998758 — Megestrol Acetate in Improving Neoadjuvant Chemotherapy-Related Weight Loss in Locally Advanced CRC · Phase 3 · recruiting
- NCT06978322 — Comparative Study Between Immediate Surgery Versus Neoadjuvant Chemotherapy for Management of Resectable Pancreatic Canc · recruiting
- NCT06220214 — Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer · EARLY_PHASE1 · recruiting
- NCT07051083 — Bladder Cancer Staging and Prediction of New Adjuvant Chemotherapy Efficacy Based on Deep Learning and Transfer Learning · recruiting
- NCT06281210 — Vabb After Neoadjuvant Therapy to Avoid Surgery-pCR to Avoid Breast Surgery · NA · recruiting
Other Acıbadem Atunizade Hospital trials
Trials by the same sponsor.
- NCT07407075 — MUSCLE STRENGTH IMBALANCE AND KINESIOPHOBIA IN MENISCUS PATIENTS · completed
- NCT06599281 — The Importance of Physiotherapy After Separation Surgery in Pygopagus Conjoined Twins · NA · not yet recruiting
- NCT06585397 — ICF-Based Evaluation of the Upper Extremity in Children With Quadriparetic Cerebral Palsy · completed
- NCT06617507 — The Effect of Selective Dorsal Rhizotomy Surgery on Walking in Children With Ambulatory Cerebral Palsy in Turkey · completed
- NCT06610370 — Predicting Postoperative Ambulation Following Selective Dorsal Rhizotomy Based on Preoperative Gross Motor Function Scor · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06151379 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Acıbadem Atunizade Hospital
- Last refreshed: 30 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06151379.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing